vancomycin-resistant enterococci

Also found in: Dictionary.
Related to vancomycin-resistant enterococci: VRE

vancomycin-resistant enterococci

Abbreviation: VRE
A strain of Enterococcus faecium resistant to antibiotics, including penicillins, aminoglycosides, and vancomycin. Infection with VRE presents a major threat to infected patients; although it can be treated with linezolid, its antibiotic resistance can be transferred to other gram-positive organisms, such as Staphylococcus aureus, making these bacteria also more difficult to eradicate.

To prevent the spread of VRE, the organism is identified by culture and sensitivity testing as soon as the infection is recognized. Contact precautions and cohorting of infected patients are used to control nosocomial spread. All persons entering the patient's room don gloves; hands are washed carefully both before they are donned and after they are removed. Gloves are removed just before leaving the room. Charts and flow sheets should not be taken into the room. Hospitals should heed the guidelines that have been developed for the use of vancomycin, to minimize the spread of vancomycin resistance to other organisms.

antibiotic resistance; multidrug resistance;
See also: Enterococcus
References in periodicals archive ?
However, information regarding the activity of fosfomycin against vancomycin-resistant enterococci in the setting of increasing fosfomycin use is limited (5).
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.
Of these bacteria, vancomycin-resistant enterococci (VRE) have been paid a particular attention (Padiglione et al.
Coossens H, jabes D, Rossi R, Lammens C, Privitera G, Courvalin R European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates.
Shortly after the first isolates of vancomycin-resistant enterococci (VRE) were reported by investigators in the United Kingdom and France, similar strains were detected in hospitals located in the eastern half of the United States.
Absence of vancomycin-resistant enterococci (VRE) despite the presence of risk factors: a survey of rectal carriage of VRE.
Effective use against microorganisms including gram-positive and gram-negative bacteria, Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococci (VRE), Clostridium difficile, Acineobacter, and most viruses and fungi.
The broad-spectrum formula includes silver dihydrogen citrate, and it has been shown to be effective against most germs and "super bugs" including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
In a report by researchers at the Hebrew Senior Life Institute for Aging, multidrug-resistant gram-negative (MDRGN) bacteria are becoming a greater problem as a source of treatment-resistant infection in long-term care (LTC) facilities than methicillin-resistant Staphylococcus aureas (MRSA) or vancomycin-resistant enterococci (VRE).
The emergence of vancomycin-resistant enterococci (VRE) is a cause of concern, as once established, it is very difficult to control.
Recent publicity about the Vancomycin-resistant Enterococci (VRE) cases that have been detected at Auckland District Health Board hospitals have caused some national discussion and concern in the New Zealand media.

Full browser ?